05 WFE Core Deposition Etch Ion Implant
The AI-driven semiconductor buildout is forcing a structural shift to 3D architectures (GAA logic, HBM, 3D NAND) that demands exponentially more deposition, etch, and ion implant steps per wafer. This creates a sustained supercycle for wafer fab equipment (WFE), with SEMI projecting record spend of $145B in 2026 and $156B in 2027. Companies that hold quasi-monopoly positions in critical process steps—ALD (ASM), coater/developer (TEL), ion implant (Axcelis/Veeco merger), and advanced etch (LRCX, AMAT)—are structural bottlenecks with pricing power and multi-year order visibility. However, extreme valuations in many names, escalating US-China export controls, and the risk of a post-AI digestion correction temper the outlook.
| Outlook | bull |
|---|
| Sentyment sektora | Bullish |
|---|
| Faza cyklu kapitałowego | mid_cycle |
|---|
| Ekspozycja na AI | Direct and structural – every AI accelerator requires advanced deposition/etch at leading nodes and HBM packaging; AI interconnect optics (CPO) also drive demand for MOCVD (Aixtron, Veeco). The AI tailwind accounts for >70% of incremental WFE spend in 2026. |
|---|
Uzasadnienie outlooku
WFE spend is in a structural upcycle, not a cyclical blip, backed by hyperscaler CapEx commitments (~$690B by 2026) and node transitions that permanently increase equipment intensity. The secular AI demand tailwind is broad-based, spanning logic, memory, and advanced packaging.
Ranking spółek
- ASM.AS — ASM International ()
- AMAT — Applied Materials ()
- VECO — Veeco Instruments ()
- 7735.T — SCREEN Holdings ()
- LRCX — Lam Research ()
- 8035.T — Tokyo Electron ()
- 6856.T — Horiba ()
- ACLS — Axcelis Technologies ()
- AIXA.DE — Aixtron SE ()
- ICHR — Ichor Holdings ()
- 6273.T — SMC Corporation ()
- MKSI — MKS Instruments ()
- UCTT — Ultra Clean Holdings ()
- 6525.T — Kokusai Electric ()
Kluczowe ryzyka
- {'risk': 'US-China export control escalation', 'timeframe': '6-18 months'}
- {'risk': 'Hyperscaler CapEx digestion', 'timeframe': '12-24 months'}
- {'risk': 'Valuation mean reversion', 'timeframe': '6-12 months'}
- {'risk': 'Supply chain constraints', 'timeframe': '12 months'}
- {'risk': 'Merger execution risk (Veeco/Axcelis)', 'timeframe': '6 months'}
Katalizatory
- {'catalyst': 'Hyperscaler AI CapEx guidance (August-October 2026) — Upward revisions from MSFT, GOOGL, AMZN, META would confirm continued WFE demand.', 'timeframe': 'August-October 2026'}
- {'catalyst': 'ASM/AMAT/LRCX/TEL Q2 2026 earnings (July-August 2026) — Order backlog updates and margin guidance; current expectations are for sequential growth.', 'timeframe': 'July-August 2026'}
- {'catalyst': 'Veeco/Axcelis merger SAMR ruling (September 2026) — Approval unlocks synergy value and confirms no anti-competitive harm.', 'timeframe': 'September 2026'}
- {'catalyst': 'TSMC N2 GAA ramp progress (H2 2026) — If TSMC announces early production milestones, ALD and etch tool orders accelerate.', 'timeframe': 'H2 2026'}
- {'catalyst': 'CHIPS Act Phase 2 awards (Q3-Q4 2026) — Additional subsidies for leading-edge fabs would boost CapEx forecasts.', 'timeframe': 'Q3-Q4 2026'}